DYNLT2B
geneOn this page
Also known as MGC33212
Summary
DYNLT2B (dynein light chain Tctex-type 2B, HGNC:28482) is a protein-coding gene on chromosome 3q29, encoding Dynein light chain Tctex-type protein 2B (Q8WW35). Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 2 complex (dynein-2 complex), a motor protein complex that drives the movement of cargos along microtubules within cilia and flagella in concert with the intraflagellar transport (IFT) system.
Dyneins are a group of microtubule-activated ATPases that function as molecular motors. They are divided into two subgroups of axonemal and cytoplasmic dyneins. The cytoplasmic dyneins function in intracellular motility, including retrograde axonal transport, protein sorting, organelle movement, and spindle dynamics. Molecules of conventional cytoplasmic dynein are comprised of 2 heavy chain polypeptides and a number of intermediate and light chains. This gene encodes a subunit of the human cytoplasmic dynein-2 complex. Mutations in this gene are associated with short-rib thoracic dysplasia 17 with or without polydactyly. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 255758 — RefSeq curated summary.
At a glance
- Gene–disease (curated): short-rib thoracic dysplasia 17 with or without polydactyly (Strong, GenCC)
- Clinical variants (ClinVar): 90 total — 9 pathogenic, 1 likely-pathogenic
- Phenotypes (HPO): 13
- MANE Select transcript:
NM_152773
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28482 |
| Approved symbol | DYNLT2B |
| Name | dynein light chain Tctex-type 2B |
| Location | 3q29 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC33212 |
| Ensembl gene | ENSG00000213123 |
| Ensembl biotype | protein_coding |
| OMIM | 617353 |
| Entrez | 255758 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 5 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000325318, ENST00000426563, ENST00000446494, ENST00000465757, ENST00000491186, ENST00000931282, ENST00000931283, ENST00000931284, ENST00000943620
RefSeq mRNA: 2 — MANE Select: NM_152773
NM_001351628, NM_152773
CCDS: CCDS33929
Canonical transcript exons
ENST00000325318 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001506975 | 196318040 | 196318240 |
| ENSE00003484696 | 196296006 | 196296069 |
| ENSE00003648804 | 196291219 | 196291374 |
| ENSE00003709844 | 196306943 | 196307012 |
| ENSE00003709845 | 196316098 | 196316231 |
Expression profiles
Bgee: expression breadth ubiquitous, 135 present calls, max score 97.96.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 20.5024 / max 351.3502, expressed in 1716 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 46339 | 14.9576 | 1689 |
| 46340 | 4.0474 | 1500 |
| 46341 | 1.4973 | 933 |
Top tissues by expression
137 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 97.96 | gold quality |
| cortical plate | UBERON:0005343 | 95.97 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 95.60 | gold quality |
| nucleus accumbens | UBERON:0001882 | 94.93 | gold quality |
| hypothalamus | UBERON:0001898 | 94.09 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 93.97 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 93.87 | gold quality |
| right testis | UBERON:0004534 | 93.63 | gold quality |
| caudate nucleus | UBERON:0001873 | 93.52 | gold quality |
| left testis | UBERON:0004533 | 93.45 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 93.45 | gold quality |
| ganglionic eminence | UBERON:0004023 | 93.43 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 93.23 | gold quality |
| amygdala | UBERON:0001876 | 93.22 | gold quality |
| temporal lobe | UBERON:0001871 | 93.17 | gold quality |
| testis | UBERON:0000473 | 92.92 | gold quality |
| putamen | UBERON:0001874 | 92.76 | gold quality |
| right frontal lobe | UBERON:0002810 | 92.70 | gold quality |
| ventricular zone | UBERON:0003053 | 92.53 | gold quality |
| cerebral cortex | UBERON:0000956 | 92.43 | gold quality |
| brain | UBERON:0000955 | 92.31 | gold quality |
| Ammon’s horn | UBERON:0001954 | 92.25 | gold quality |
| primary visual cortex | UBERON:0002436 | 91.80 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 91.61 | gold quality |
| frontal cortex | UBERON:0001870 | 91.56 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 91.43 | gold quality |
| cerebellar cortex | UBERON:0002129 | 91.32 | gold quality |
| pituitary gland | UBERON:0000007 | 91.23 | gold quality |
| cerebellum | UBERON:0002037 | 91.17 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 91.06 | gold quality |
Single-cell (SCXA)
Detected in 6 experiment(s), a significant marker in 5.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 61.28 |
| E-HCAD-1 | yes | 27.45 |
| E-MTAB-10287 | yes | 27.02 |
| E-ANND-3 | yes | 9.66 |
| E-MTAB-9388 | yes | 7.12 |
| E-MTAB-7606 | no | 416.29 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
11 targeting DYNLT2B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-16-2-3P | 99.29 | 70.60 | 1954 |
| HSA-MIR-195-3P | 99.29 | 70.61 | 1954 |
| HSA-MIR-520E-5P | 99.27 | 68.90 | 1513 |
| HSA-MIR-3145-3P | 98.85 | 69.07 | 2031 |
| HSA-MIR-6755-3P | 98.61 | 66.90 | 834 |
| HSA-MIR-5000-5P | 97.40 | 66.11 | 1055 |
Literature-anchored findings (GeneRIF, showing 3)
- Tctex1d2 is a novel dynein light chain important for trafficking to the cilium and potentially retrograde intraflagellar transport. (PMID:25830415)
- integral component of the evolutionarily conserved retrograde intraflagellar transport machinery (PMID:26044572)
- WDR60 plays a major role and TCTEX1D2 plays an auxiliary role in the dynein-2 complex to mediate retrograde ciliary protein trafficking. (PMID:29742051)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dynlt2b | ENSDARG00000054255 |
| mus_musculus | Dynlt2b | ENSMUSG00000014075 |
| rattus_norvegicus | Dynlt2b-ps1 | ENSRNOG00000000630 |
| rattus_norvegicus | Dynlt2b | ENSRNOG00000001758 |
| drosophila_melanogaster | CG14763 | FBGN0033243 |
| caenorhabditis_elegans | WBGENE00017014 |
Paralogs (5): DYNLT1 (ENSG00000146425), DYNLT5 (ENSG00000152760), DYNLT3 (ENSG00000165169), DYNLT2 (ENSG00000184786), DYNLT4 (ENSG00000188396)
Protein
Protein identifiers
Dynein light chain Tctex-type protein 2B — Q8WW35 (reviewed: Q8WW35)
Alternative names: Tctex1 domain-containing protein 2
All UniProt accessions (3): E7ER86, F8WD40, Q8WW35
UniProt curated annotations — full annotation on UniProt →
Function. Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 2 complex (dynein-2 complex), a motor protein complex that drives the movement of cargos along microtubules within cilia and flagella in concert with the intraflagellar transport (IFT) system. Required for proper retrograde ciliary transport.
Subunit / interactions. Light chain of the cytoplasmic dynein complex 2, a multisubunit complex composed at least of eleven different proteins. The cytoplasmic dynein 2 complex consists of two catalytic heavy chains (HCs) and a number of non-catalytic subunits presented by intermediate chains (ICs), light intermediate chains (LICs) and light chains (LCs). Among them, a heavy chain (DYNC2H1), two intermediate chains (DYNC2I2 and DYNC2I1), a light intermediate chain (DYNC2LI1), and a light chain (DYNLT2B) are unique to the dynein-2 complex, but a subset of the light chains are also shared by dynein-1 and dynein-2 complexes. Interacts with DYNC2I1. The dimer DYNLT2B-DYNLT1/DYNLT3 interacts with DYNC2I1; this interaction is crucial for retrograde trafficking of ciliary proteins.
Subcellular location. Dynein axonemal particle.
Disease relevance. Short-rib thoracic dysplasia 17 with or without polydactyly (SRTD17) [MIM:617405] A form of short-rib thoracic dysplasia, a group of autosomal recessive ciliopathies that are characterized by a constricted thoracic cage, short ribs, shortened tubular bones, and a ’trident’ appearance of the acetabular roof. Polydactyly is variably present. Non-skeletal involvement can include cleft lip/palate as well as anomalies of major organs such as the brain, eye, heart, kidneys, liver, pancreas, intestines, and genitalia. Some forms of the disease are lethal in the neonatal period due to respiratory insufficiency secondary to a severely restricted thoracic cage, whereas others are compatible with life. Disease spectrum encompasses Ellis-van Creveld syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Mainzer-Saldino syndrome, and short rib-polydactyly syndrome. The disease is caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the dynein light chain Tctex-type family.
RefSeq proteins (2): NP_001338557, NP_689986* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005334 | Tctex-1-like | Family |
| IPR038586 | Tctex-1-like_sf | Homologous_superfamily |
Pfam: PF03645
UniProt features (13 total): strand 5, helix 4, chain 1, sequence variant 1, turn 1, sequence conflict 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8RGI | X-RAY DIFFRACTION | 2.02 |
| 8J07 | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WW35-F1 | 86.89 | 0.72 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-5620924 | Intraflagellar transport |
MSigDB gene sets: 195 (showing top):
GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS, DARWICHE_SKIN_TUMOR_PROMOTER_UP, DARWICHE_PAPILLOMA_RISK_LOW_UP, DARWICHE_PAPILLOMA_RISK_HIGH_DN, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS, GOCC_MICROTUBULE_ORGANIZING_CENTER, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOBP_CILIUM_ORGANIZATION, GOBP_REGULATION_OF_CELLULAR_LOCALIZATION, GOCC_CENTROSOME, GOBP_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT, GOBP_ORGANELLE_ASSEMBLY, GOBP_REGULATION_OF_CILIUM_ASSEMBLY
GO Biological Process (5): microtubule-based movement (GO:0007018), intraciliary retrograde transport (GO:0035721), cilium assembly (GO:0060271), regulation of cilium assembly (GO:1902017), regulation of intraciliary retrograde transport (GO:1905799)
GO Molecular Function (2): dynein intermediate chain binding (GO:0045505), protein binding (GO:0005515)
GO Cellular Component (9): cytoplasm (GO:0005737), cytoplasmic dynein complex (GO:0005868), cilium (GO:0005929), dynein axonemal particle (GO:0120293), spindle pole (GO:0000922), centrosome (GO:0005813), axoneme (GO:0005930), interphase microtubule organizing center (GO:0031021), ciliary base (GO:0097546)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Assembly of the 9+0 primary cilium | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| microtubule organizing center | 2 |
| microtubule-based process | 1 |
| intraciliary transport | 1 |
| axoneme assembly | 1 |
| intraciliary transport involved in cilium assembly | 1 |
| cilium organization | 1 |
| protein localization to cilium | 1 |
| organelle assembly | 1 |
| trans-Golgi to periciliary membrane compartment transport | 1 |
| plasma membrane bounded cell projection assembly | 1 |
| ciliary transition zone assembly | 1 |
| cilium assembly | 1 |
| regulation of plasma membrane bounded cell projection assembly | 1 |
| regulation of organelle assembly | 1 |
| regulation of intracellular transport | 1 |
| intraciliary retrograde transport | 1 |
| regulation of microtubule-based movement | 1 |
| protein binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| dynein complex | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cytoplasm | 1 |
| intracellular membraneless organelle | 1 |
| spindle | 1 |
| centriole | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| cilium | 1 |
| ciliary transition zone | 1 |
| ciliary transition fiber | 1 |
Protein interactions and networks
STRING
713 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DYNLT2B | DYNC2I1 | Q8WVS4 | 922 |
| DYNLT2B | DYNC2LI1 | Q8TCX1 | 904 |
| DYNLT2B | DYNC2I2 | Q96EX3 | 874 |
| DYNLT2B | DYNC2H1 | Q8NCM8 | 866 |
| DYNLT2B | DYNLRB1 | Q9NP97 | 737 |
| DYNLT2B | DYNLT3 | P51808 | 709 |
| DYNLT2B | DYNLRB2 | Q8TF09 | 703 |
| DYNLT2B | SMCO1 | Q147U7 | 649 |
| DYNLT2B | WDR53 | Q7Z5U6 | 643 |
| DYNLT2B | DYNLL2 | Q96FJ2 | 642 |
| DYNLT2B | CEP120 | Q8N960 | 623 |
| DYNLT2B | WDR19 | Q8NEZ3 | 618 |
| DYNLT2B | DYNLT1 | P63172 | 605 |
| DYNLT2B | IFT140 | Q96RY7 | 604 |
| DYNLT2B | DYNLL1 | P63167 | 587 |
IntAct
57 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DYNLT1 | DYNLT2B | psi-mi:“MI:0915”(physical association) | 0.790 |
| DYNLT2B | DYNLT1 | psi-mi:“MI:0914”(association) | 0.790 |
| DYNLL1 | BLTP3B | psi-mi:“MI:0914”(association) | 0.730 |
| DYNLT1 | DYNC1LI2 | psi-mi:“MI:0914”(association) | 0.640 |
| DYNC2I2 | DYNLL1 | psi-mi:“MI:0914”(association) | 0.640 |
| DYNLL2 | BLTP3B | psi-mi:“MI:0914”(association) | 0.640 |
| ACTN2 | DYNLT2B | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDKN2D | DYNLT2B | psi-mi:“MI:0915”(physical association) | 0.560 |
| DYNLT2B | SNX2 | psi-mi:“MI:0914”(association) | 0.530 |
| COMMD10 | VPS26C | psi-mi:“MI:0914”(association) | 0.530 |
| DEFB121 | COL6A2 | psi-mi:“MI:0914”(association) | 0.530 |
| GTF2F2 | DYNLT2B | psi-mi:“MI:0915”(physical association) | 0.520 |
| DYNLRB2 | PAFAH1B1 | psi-mi:“MI:0914”(association) | 0.510 |
| DYNLT2B | TIPRL | psi-mi:“MI:0914”(association) | 0.510 |
| DYNC2I1 | ZRANB2 | psi-mi:“MI:0914”(association) | 0.510 |
| DYNLT2B | CSNK2B | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPP2CB | DYNLT2B | psi-mi:“MI:0915”(physical association) | 0.370 |
| TK1 | DYNLT2B | psi-mi:“MI:0915”(physical association) | 0.370 |
| VWA2 | WDR47 | psi-mi:“MI:0914”(association) | 0.350 |
| ABHD17A | DYNLT2B | psi-mi:“MI:0914”(association) | 0.350 |
| DYNC2LI1 | DYNLT1 | psi-mi:“MI:0914”(association) | 0.350 |
| LETM2 | GAPDHS | psi-mi:“MI:0914”(association) | 0.350 |
| NDUFB3 | NDUFS4 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (60): TCTEX1D2 (Affinity Capture-MS), TCTEX1D2 (Proximity Label-MS), TCTEX1D2 (Two-hybrid), WDR60 (Affinity Capture-MS), TCTEX1D2 (Affinity Capture-MS), TCTEX1D2 (Affinity Capture-MS), WDR34 (Affinity Capture-MS), TCTEX1D2 (Affinity Capture-MS), TCTEX1D2 (Affinity Capture-MS), ABHD17B (Affinity Capture-MS), CLMN (Affinity Capture-MS), ABTB2 (Affinity Capture-MS), SNX6 (Affinity Capture-MS), SNX2 (Affinity Capture-MS), TCTEX1D2 (Affinity Capture-MS)
ESM2 similar proteins: A7T1N0, B2RR83, F1QMY1, F1S5L4, O13648, O42857, O75343, P08487, P10686, P11985, P19174, P22717, P56523, P97311, P97564, Q04861, Q09315, Q14566, Q14BI7, Q21557, Q28BS0, Q28CM3, Q29JI9, Q2KIZ8, Q32P71, Q39579, Q3MHU3, Q4V339, Q5FWY4, Q5JTY5, Q5R746, Q5RIA9, Q5ZI74, Q61586, Q62077, Q6DNF3, Q8IUF1, Q8IZS6, Q8NDG6, Q8VEH6
Diamond homologs: A2VDD2, Q32P71, Q3B8D7, Q4VYA0, Q54PG1, Q5JR98, Q66IC8, Q8CDY7, Q8N7M0, Q8WW35, Q9CQ66, Q9D5I4, F1QMY1, P11985, P51807, Q8IZS6, Q94524, P51808, P56387, P63171, P63172, Q5NVF5, Q6XXL8, Q8SPS9, Q9Z336
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 45 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Intraflagellar transport | 7 | 43.8× | 4e-08 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 5 | 18.2× | 4e-04 |
| Resolution of Sister Chromatid Cohesion | 6 | 16.2× | 2e-04 |
| RHO GTPases Activate Formins | 6 | 14.6× | 3e-04 |
| EML4 and NUDC in mitotic spindle formation | 5 | 14.5× | 7e-04 |
| Mitotic Prometaphase | 6 | 13.0× | 4e-04 |
| Separation of Sister Chromatids | 5 | 9.5× | 5e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| microtubule-based movement | 6 | 41.2× | 1e-06 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
90 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 9 |
| Likely pathogenic | 1 |
| Uncertain significance | 40 |
| Likely benign | 26 |
| Benign | 9 |
Top pathogenic / likely-pathogenic (10)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2192828 | NM_152773.5(DYNLT2B):c.104dup (p.Gln36fs) | Pathogenic |
| 266107 | NM_152773.5(DYNLT2B):c.317+4A>T | Pathogenic |
| 3649518 | NM_152773.5(DYNLT2B):c.221C>G (p.Ser74Ter) | Pathogenic |
| 3660585 | NM_152773.5(DYNLT2B):c.193G>T (p.Glu65Ter) | Pathogenic |
| 394282 | GRCh37/hg19 3q29(chr3:195780280-196264407)x3 | Pathogenic |
| 417792 | NM_152773.5(DYNLT2B):c.262C>T (p.Arg88Ter) | Pathogenic |
| 417793 | NM_152773.5(DYNLT2B):c.100delinsCT (p.Val34fs) | Pathogenic |
| 4729518 | NM_152773.5(DYNLT2B):c.263del (p.Arg88fs) | Pathogenic |
| 686054 | GRCh37/hg19 3q29(chr3:195701149-197348561)x3 | Pathogenic |
| 813328 | GRCh37/hg19 3q29(chr3:196033814-196033883) | Likely pathogenic |
SpliceAI
1448 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:196306941:A:AC | donor_gain | 1.0000 |
| 3:196306942:C:CC | donor_gain | 1.0000 |
| 3:196306942:CAATA:C | donor_gain | 1.0000 |
| 3:196307008:CATTT:C | acceptor_gain | 1.0000 |
| 3:196307010:TTT:T | acceptor_gain | 1.0000 |
| 3:196307013:C:CC | acceptor_gain | 1.0000 |
| 3:196318028:T:TA | donor_gain | 1.0000 |
| 3:196318083:C:CA | donor_gain | 1.0000 |
| 3:196318084:C:A | donor_gain | 1.0000 |
| 3:196318099:AG:A | donor_gain | 1.0000 |
| 3:196296004:A:AC | donor_gain | 0.9900 |
| 3:196296005:C:CC | donor_gain | 0.9900 |
| 3:196296005:CATT:C | donor_gain | 0.9900 |
| 3:196296068:TG:T | acceptor_gain | 0.9900 |
| 3:196296070:C:CC | acceptor_gain | 0.9900 |
| 3:196307009:ATTT:A | acceptor_gain | 0.9900 |
| 3:196307011:TT:T | acceptor_gain | 0.9900 |
| 3:196307011:TTCT:T | acceptor_loss | 0.9900 |
| 3:196307012:TC:T | acceptor_loss | 0.9900 |
| 3:196307012:TCTA:T | acceptor_loss | 0.9900 |
| 3:196307013:C:CA | acceptor_loss | 0.9900 |
| 3:196307014:T:A | acceptor_loss | 0.9900 |
| 3:196316084:A:AC | donor_gain | 0.9900 |
| 3:196317957:T:TA | donor_gain | 0.9900 |
| 3:196317987:C:A | donor_gain | 0.9900 |
| 3:196318095:T:TA | donor_gain | 0.9900 |
| 3:196318136:C:CA | donor_gain | 0.9900 |
| 3:196292488:T:C | acceptor_gain | 0.9800 |
| 3:196296065:CCATG:C | acceptor_gain | 0.9800 |
| 3:196296066:CATG:C | acceptor_gain | 0.9800 |
AlphaMissense
942 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:196291360:G:C | C132W | 0.999 |
| 3:196291343:C:T | G138D | 0.998 |
| 3:196291363:G:C | F131L | 0.998 |
| 3:196291363:G:T | F131L | 0.998 |
| 3:196291365:A:G | F131L | 0.998 |
| 3:196296035:C:G | D118H | 0.998 |
| 3:196296050:A:G | W113R | 0.998 |
| 3:196296050:A:T | W113R | 0.998 |
| 3:196291361:C:T | C132Y | 0.997 |
| 3:196291362:A:G | C132R | 0.997 |
| 3:196296034:T:A | D118V | 0.997 |
| 3:196306967:C:T | G98E | 0.997 |
| 3:196306990:T:A | K90N | 0.997 |
| 3:196306990:T:G | K90N | 0.997 |
| 3:196316190:A:G | L52P | 0.996 |
| 3:196316214:A:T | V44D | 0.996 |
| 3:196316229:A:G | F39S | 0.996 |
| 3:196291345:A:C | F137L | 0.995 |
| 3:196291345:A:T | F137L | 0.995 |
| 3:196291347:A:G | F137L | 0.995 |
| 3:196296033:G:C | D118E | 0.995 |
| 3:196296033:G:T | D118E | 0.995 |
| 3:196296034:T:G | D118A | 0.995 |
| 3:196296035:C:A | D118Y | 0.995 |
| 3:196296058:C:G | R110P | 0.995 |
| 3:196306982:A:T | V93E | 0.995 |
| 3:196291336:G:C | F140L | 0.993 |
| 3:196291336:G:T | F140L | 0.993 |
| 3:196291338:A:G | F140L | 0.993 |
| 3:196291344:C:G | G138R | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000234732 (3:196319988 T>A,C,G), RS1000287728 (3:196307555 G>A), RS1000357265 (3:196318351 CG>C), RS1000565021 (3:196315647 T>G), RS1000616376 (3:196311337 G>A), RS1000625414 (3:196319015 G>A,T), RS1000690092 (3:196320227 C>T), RS1001045147 (3:196301319 T>G), RS1001098664 (3:196294464 G>A), RS1001286698 (3:196301289 T>A), RS1001334379 (3:196307599 G>A), RS1001443065 (3:196301479 G>A), RS1001493510 (3:196307585 G>C), RS1001559931 (3:196313589 T>A,C), RS1001610840 (3:196313915 T>C)
Disease associations
OMIM: gene MIM:617353 | disease phenotypes: MIM:617405, MIM:613091
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| short-rib thoracic dysplasia 17 with or without polydactyly | Strong | Autosomal recessive |
ClinGen Gene-Disease Validity (1)
Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.
| Disease | Classification | Inheritance |
|---|---|---|
| short-rib thoracic dysplasia 17 with or without polydactyly | Limited | AR |
Mondo (2): short-rib thoracic dysplasia 17 with or without polydactyly (MONDO:0054565), asphyxiating thoracic dystrophy 3 (MONDO:0013127)
Orphanet (4): Jeune syndrome (Orphanet:474), Short rib-polydactyly syndrome, Majewski type (Orphanet:93269), Short rib-polydactyly syndrome, Saldino-Noonan type (Orphanet:93270), Short rib-polydactyly syndrome, Verma-Naumoff type (Orphanet:93271)
HPO phenotypes
13 total (13 of 13 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000773 | Short ribs |
| HP:0000774 | Narrow chest |
| HP:0000888 | Horizontal ribs |
| HP:0000895 | Lateral clavicle hook |
| HP:0001156 | Brachydactyly |
| HP:0001162 | Postaxial hand polydactyly |
| HP:0001522 | Death in infancy |
| HP:0001830 | Postaxial foot polydactyly |
| HP:0003577 | Congenital onset |
| HP:0004322 | Short stature |
| HP:0010454 | Acetabular spurs |
| HP:0034374 | Trident acetabulum |
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C537602 | Short rib-polydactyly syndrome, Verma-Naumoff type (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
26 total (human), top 26 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation, increases expression | 4 |
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| Cyclosporine | decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| Esketamine | decreases expression | 1 |
| decabromobiphenyl ether | affects expression | 1 |
| dimethylselenide | decreases expression, increases expression, increases oxidation | 1 |
| sodium arsenite | decreases expression, increases abundance | 1 |
| beta-methylcholine | affects expression | 1 |
| monomethylarsonous acid | decreases expression | 1 |
| abrine | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Arsenic | decreases expression, increases abundance | 1 |
| Estradiol | decreases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Quercetin | increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Thimerosal | increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Valproic Acid | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Hydroxyl Radical | decreases expression, increases expression, increases oxidation | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: short-rib thoracic dysplasia 17 with or without polydactyly
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): asphyxiating thoracic dystrophy 3, short-rib thoracic dysplasia 17 with or without polydactyly